Trials / Completed
CompletedNCT06219278
A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Candela Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a retrospective chart review of data from the multi-site prospective clinical trial, "Functional Usability and Feasibility Testing of the Profound Matrix™ System (FUFT2002)" to evaluate the safety and efficacy of the Profound Matrix System Matrix Pro applicator for the treatment of wrinkles.
Detailed description
This was a retrospective medical record review of subject data from the source study FUFT2002 to evaluate the safety, efficacy, tolerability, and usability of the Profound MatrixTM System with the Matrix Pro Applicator for the treatment of wrinkles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Profound Matrix | The source study consisted of up to three treatment visits with treatment intervals 6 weeks ± 2 weeks |
Timeline
- Start date
- 2023-10-29
- Primary completion
- 2023-12-29
- Completion
- 2024-07-01
- First posted
- 2024-01-23
- Last updated
- 2024-10-08
- Results posted
- 2024-09-19
Locations
2 sites across 2 countries: United States, Israel
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06219278. Inclusion in this directory is not an endorsement.